Pyxis Oncology
PYXS
PYXS
38 hedge funds and large institutions have $36.6M invested in Pyxis Oncology in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
23% less capital invested
Capital invested by funds: $47.7M → $36.6M (-$11.1M)
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$155K | |
| 2 | +$135K | |
| 3 | +$105K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$98.5K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$64K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$1.6M | |
| 3 | -$372K | |
| 4 |
Millennium Management
New York
|
-$104K |
| 5 |
E
Ergoteles
New York
|
-$87K |